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Abstract 
Background: Radial dysplasia (RD) is a disfiguring, potentially disabling congenital upper limb anomaly. 
Multiple surgical techniques are in current use, with little agreement on the optimal treatment 
approach. At present, no core outcome set exists specifically for radial dysplasia, and the literature is 
dominated by retrospective case series. A recent systematic review by this group demonstrated 
significant heterogeneity in both which outcomes are measured, and how they are measured.  
Methods: The RADIATE study will conduct a three-round online Delphi process, involving adult radial 
dysplasia patients, the parents of children with radial dysplasia, hand surgeons and hand therapists. 
The initial list of outcomes is drawn from our recent systematic review and will be supplemented by 
suggestions from the stakeholder groups. Following the Delphi process, outcomes which meet the 
‘consensus in’ definition will be ratified at a final consensus meeting. 
We will then follow the COSMIN guidelines to select outcome 
measurement instruments; where appropriate, these will overlap with the outcome measures 
specified in the forthcoming ICHOM congenital upper limb anomalies standard set. 
Discussion: The Radial Dysplasia Assessment, Treatment and Aetiology (RADIATE) study aims to 
address the uncertainty in the treatment of radial dysplasia, and to begin to answer the question 
“what is the most appropriate treatment of the forearm and hand for children with radial dysplasia?” 
by establishing a core outcome set. 
 
Trial registration: COMET initiative study 902, registered May 2016 http://www.comet-
initiative.org/studies/details/902  
Keywords 
Radial dysplasia: Congenital upper limb anomalies: core outcome set: Congenital hand surgery  
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Background 
Radial dysplasia (RD) is a disfiguring, potentially disabling congenital upper limb anomaly, affecting 
approximately 1:8,000 births[1-3]. It is characterised by variable absence or hypoplasia of the pre-axial 
upper limb skeleton (radius, thumb) and soft tissues[4]. Affected children have a phenotype ranging 
from isolated thumb hypoplasia to complete absence of the thumb and radius, with severe ulnar 
bowing, elbow stiffness and humeral hypoplasia. Children may be unilaterally or bilaterally affected. 
Known causes include spontaneous mutations, teratogenic drugs and syndromes such as Holt-Oram, 
VACTERL or Fanconi anaemia, although approximately 50% of cases are of unknown aetiology. 
Children without associated major comorbidities can expect a normal lifespan.  
 
Globally, several treatment techniques to address the “wrist” deformity are in common use at 
specialist centres, including centralisation [5] or radialisation [6] of the ulna, either with or without 
prior soft-tissue distraction [7], or alternately microvascular transfer of a toe joint to act as a radial 
buttress to the wrist [8]. The surgical treatment of the soft tissues is highly variable. A recent 
systematic review by our group found patients suffer poor forearm growth and some degree of 
recurrent radial ‘wrist’ deviation, whether treated surgically or conservatively[9]. Currently, there is 
no core outcome set specifically for RD, although a generalised congenital upper limb anomaly 
standard set is due to be published soon [10]. Outcome measurement is further complicated because 
the limb changes during growth, necessitating follow-up to skeletal maturity before the final outcome 
can be assessed. 
 
The Radial Dysplasia Assessment, Treatment and Aetiology (RADIATE) study aims to address the 
uncertainty in the treatment of radial dysplasia, and to begin to answer the question “what is the most 
appropriate treatment of the forearm and hand for children with radial dysplasia?” by establishing a 
core outcome set. 
 
Selection of outcomes for use in clinical studies of radial dysplasia 
Clinical studies, whether interventional or observational, should have prospectively defined primary 
and secondary outcomes that answer the question(s) posed by the hypothesis. However, for existing 
studies of RD, the outcomes measured are numerous and highly variable between studies. The 
techniques for measuring many outcomes are also poorly defined, making it difficult to compare 
studies, or synthesise their results in a meta-analysis. It is also unclear how relevant, if at all, these 
outcomes are to patients themselves. 
 
Outcome reporting bias 
Another problem, especially in the surgical literature, is outcome reporting bias [11], where a large 
number of outcomes are measured but only those which show ‘interesting’ or ‘positive’ results are 
reported. This presents a biased view of the results of a trial, and by increasing the number of tests 
run, increases the risk of results arising by chance erroneously being labelled significant.  
 
Core outcome sets 
The development of core outcome sets (COS) is one initiative to overcome 
these problems. These prospectively defined groups of outcomes represent the minimum dataset that 
trials in a given area should report. For paediatric conditions, they are ideally developed with patient 
and family involvement. By prospectively specifying the outcomes, and how they are measured, they 
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prevent ‘cherry-picking’ of positive results, and standardise studies, allowing comparison and 
synthesis of their results. When developed with patients and their families, they also provide 
reassurance that the outcomes are relevant to patients. 
 
Scope, Aim and objectives 
Aim 
The aim of this study is to develop an initial COS suitable for assessing treatment outcomes after any 
form of treatment, including conservative management, for congenital upper 
limb anomalies in patients with RD.  
 
Scope 
The COS is designed for use in both research and routine clinical care, in any healthcare system treating 
congenital upper limb anomalies in RD. It should cover children of all ages and adults, and should apply 
to all interventions for congenital upper limb anomalies in patients with RD. 
. 
 
Objectives 
The specific study objectives are to list all outcomes previously reported in studies of the treatment 
of RD, identified through a systematic review of the literature; to prioritise outcomes from the 
perspective of patients, parents and clinicians; to compare patient/parent important and clinician 
important outcomes; and to integrate these outcomes into a combined COS. 
 
Methods 
Systematic review 
We have recently published a systematic review of the long term outcomes of both surgical and 
conservative treatment for radial dysplasia[9]. This was prospectively registered with the PROSPERO 
database (CRD42016036665) and conducted using the Cochrane highly sensitive search strategy. We 
searched Medline and Embase via OvidSP, PubMed, Cochrane, ClinicalTrials.gov and the WHO 
International Clinical Trials portal for published and unpublished studies. Searches were not restricted 
by date or language. From all studies identified which reported outcomes for RD treatment, we 
have extracted a list of outcomes measured for radial dysplasia following the process in the COMET 
handbook[12] (section 2.7.1.2), which will form the starting point for our Delphi process. 
 
Identification of outcomes of importance to patients, parents and clinicians 
Overview 
To achieve consensus on a COS for RD within and between groups, we propose to use an online Delphi 
process, adapted and simplified from the protocol laid out by Harman et al [13]. This will include four 
groups of participants;  
• RD patients aged over 16 
• Parents of RD patients aged under 16 
• Hand therapists who treat RD patients 
• Hand surgeons who treat RD patients 
These groups were chosen to reflect patient and family perspectives equally with surgical and 
therapist perspectives. We aim to make the groups of similar size. Patient and parent groups will be 
drawn from across the UK, and clinician groups drawn from specialist centres internationally. The 
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study will be managed from Great Ormond St Hospital in London, and participants will be recruited 
via email by the central research team, following identification by participating specialist centres 
worldwide. The Delphi process will be administered using the secure DelphiManager software at the 
University of Liverpool. The study process is summarised in figure 1. 
 
Identification of potential outcomes 
Our initial outcome list has been generated from the outcomes identified during our 
systematic review. We included all outcomes that we identified in the global literature on RD 
treatment. Composite outcome scores have been split into their component parts, where possible. 
The outcome list will be presented thematically, by outcome domain.. Outcomes 
will be described using lay language, then medical language beneath, with a diagram or picture as 
required. The draft outcome list will be piloted with members of all stakeholder groups before use to 
ensure it is easily understood and clear. 
 
Participants and stakeholder selection 
We aim to recruit the patient and parent groups via specialist centres across the UK, and the 
therapist and surgeon groups from global specialist centres. All participants will be required to be 
proficient with spoken and written English, and to have access to a computer and internet connection. 
 
Delphi Process 
Round 1 – initial ranking and finalising outcomes considered 
Participant identification centres have been identified by the review authors. Potential participants 
will be identified by each centre locally, then invited to participate in the Delphi process by the central 
research team at Great Ormond St. Those who agree will be invited to register with the DelphiManager 
platform, then sent an email linking to an online survey, listing each identified outcome 
thematically, by outcome domain, and providing an open question at the end to 
nominate important missing outcomes. They will be asked to 
rank each outcome 1-9, where 1-3 is ‘not important’, 4-6 is ‘important but not critical’ and 7-9 is 
‘critical’. The online survey will allow a review author (GM), who will not himself participate, to 
identify who has completed the survey. Participants will be given three weeks to complete the survey, 
with a reminder email being sent after one and two weeks.  
 
Analysis of round 1 
Newly suggested outcomes will be reviewed by two review authors (GM and BS) to ensure they are 
genuinely novel, then combined and added to the round two questionnaire accordingly. 
Results will be analysed by participant group and in overall summary, noting the number participating 
and the distribution of scores per outcome. Outcomes meeting the ‘consensus out’ definition will be 
excluded from the round two questionnaire. Individual participation in round two will be contingent 
upon completing the survey in round one. 
 
Round 2  
Participants will again be contacted by email with a link to the online survey. For each previously 
scored outcome, they will be presented with a histogram summary of the responses for each group 
and for all groups combined, plus a reminder of their previous score. They will then be asked to 
re-score each outcome, again from 1-9, and then to score any newly suggested outcomes identified 
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in round one. Participants will be given three weeks to complete the round two survey, with a 
reminder email being sent after one and two weeks. 
 
Analysis of round 2 
Results will be analysed both by participant group and in overall summary, noting the number 
participating and the distribution of scores per outcome. Outcomes meeting the ‘consensus out’ 
definition will be excluded from the round three questionnaire. Individual participation in round three 
will again be contingent upon completing the survey in round two. 
 
Round 3  
Participants will again be contacted by email with a link to the online survey. For each outcome they 
will be presented with a histogram summary of the responses for each group and for all groups 
combined, plus a reminder of their round 2 score. They will then be asked to re-score each 
outcome, again from 1-9. Participants will be given three weeks to complete the round three survey, 
with a reminder email being sent after one and two weeks. 
 
Analysis of round 3 
Results will be analysed both by participant group and in overall summary, noting the number 
participating and the distribution of scores per outcome. Outcomes will be classified as consensus in, 
consensus out or no consensus using the criteria in table 1. The distribution of scores and consensus 
result for each outcome will be displayed by group and overall and used to structure the final 
consensus meeting. 
 
Consensus meeting 
A final consensus will be reached during a consensus meeting, which may involve a mixture of face to 
face and teleconference participation. All participants in the Delphi survey will be invited. All 
participants will receive the results of round three in advance, presented by group and overall. 
We will then follow the COSMIN guidelines to select outcome measurement instruments. To avoid 
We will then follow the COSMIN guidelines to 
select outcome measurement instruments. To avoid duplication of effort by patients, clinicians and 
researchers, we will measure outcomes which overlap with the ICHOM 
standard set for congenital upper limb anomalies in the same way. The final COS will be published in 
a peer-reviewed journal. 
 
Definition of consensus 
We will use the definition of consensus from Harman et al [13], summarised in table 1. This will be 
applied to the combined group scores from round 3. 
 
Statistical analysis and Sample size 
Scores for each item will be presented as a histogram of responses, and the percentage of responses 
in each group (1-3, 4-6, 7-9) calculated. This will be done by individual stakeholder group, and for all 
groups combined. 
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As there is no standard model for the sample size required for a Delphi process, we will aim for 
between 10 - 15 participants per group, with the patient and parent groups covering patients with a 
variety of disease severity and age. 
 
Discussion 
There is currently no core outcome set specifically for radial dysplasia. This study seeks to develop 
one, with the involvement of a wide range of participants, to ensure maximal acceptability to both 
patients and clinicians.  
 
As with any project, this study has limitations. The long-list of outcomes has been developed from a 
comprehensive systematic review, but it is possible that we have missed relevant outcomes, especially 
those not represented in the existing literature. Supplementing the initial list with qualitative 
interviews is one approach suggested in the COMET handbook[12], but is beyond the resources of this 
project. By allowing all stakeholders to suggest further outcomes in round one of the Delphi process, 
we aim to reduce this risk to acceptable levels, but must concede that this approach “does not have 
the same standing as the knowledge generated by [qualitative] research”[12]. 
 
The choice of stakeholders has been informed by current treatment protocols for RD. Primary surgery 
typically happens before the patient is aged 2, meaning that parents are the key early decision makers, 
whose views we wish to include. We aim to reflect the independent views of RD children both by 
encouraging parents to involve their children as much as is age and developmentally appropriate in 
completing the survey, and by including a separate group of RD patients aged over 16. Together with 
the international groups of surgeons and hand therapists, we believe this provides a balanced 
perspective on RD treatment. 
 
Where outcomes overlap, we will use the same measurement 
instruments as the recently developed ICHOM congenital upper limb anomalies standard 
set[10], so that patients and clinicians are not unduly burdened by multiple outcome measurement. 
This standard set includes measurement instruments that were chosen through a methodologically 
robust Delphi process, informed by patient focus groups and the literature, 
We hope that this outcome set will make the interpretation, comparison and synthesis of future 
studies easier. 
 
Study Status 
The study protocol is version 1.0 (18 July 2018). Recruitment  commenced on 28 November 
 2018, and is expected to be complete beforeJune 2019. The study is 
expected to take 3 months once fully recruited to. 
 
List of abbreviations 
BSSH  British Society for Surgery of the Hand 
COS  Core Outcome Set 
ICHOM  International Consortium for Health Outcomes Measurement 
PROSPERO International Prospective Register of Systematic Reviews 
RADIATE Radial Dysplasia: Assessment, Treatment and Aetiology 
RD  Radial Dysplasia 
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Figure legends 
 
Figure 1 – SPIRIT figure; schedule of enrolment, interventions, and assessments. 
 
 
Table 1 – Definition of consensus (after Harman [13]) 
 
 
 
